Thirty-five clinical isolates of Legionella species were tested agains
t 7 antimicrobial agents using an agar dilution technique. Results obt
ained on charcoal-supplemented (BCYE) and charcoal-free agar (BSYE) we
re compared. On BCYE, the most active agent was rifampicin; the minima
l inhibitory concentration inhibiting 90% of the strains (MIC90) was 0
.008 mg/L. Imipenem was the next most active in vitro (MIC90 0.06 mg/L
). The macrolide antibiotics and ciprofloxacin also inhibited the orga
nisms at low concentrations (MIC90 less-than-or-equal-to 2 mg/L). In g
eneral, MIC's obtained on BCYE agar were at least twofold higher than
on BSYE agar except for that of imipenem. BSYE agar is a suitable alte
rnative medium for susceptibility testing of most Legionella species.
Erythromycin and rifampicin continue to demonstrate good in vitro acti
vity against legionellae in Australia. On the basis of in vitro suscep
tibility tests, the other macrolides and ciprofloxacin are likely to b
e suitable alternatives for the treatment of legionellosis.